Strs Ohio Genprex, Inc. Transaction History

Strs Ohio

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 23, 2021	SELL	$3.66 - $7.67 $7,320 - $15,340	-2,000 Closed	0 $0
Q3 2020 Dec 14, 2020	SELL	$2.9 - $4.29 $15,370 - $22,737	-5,300 Reduced 72.6%	2,000 $6,000
Q2 2020 Jul 23, 2020	BUY	$1.99 - $3.64 $14,527 - $26,572	7,300 New	7,300 $22,000

600

Ticker GNPX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,300
Market Cap $64.3M
Description
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incor...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.